A detailed history of West End Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, West End Advisors, LLC holds 5 shares of DXCM stock, worth $389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$389
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$110.31 - $140.45 $110 - $140
-1 Reduced 16.67%
5 $0
Q4 2023

Jan 18, 2024

BUY
$75.49 - $124.16 $75 - $124
1 Added 20.0%
6 $0
Q3 2023

Oct 19, 2023

BUY
$86.06 - $137.93 $430 - $689
5 New
5 $0
Q2 2022

Jul 28, 2022

BUY
$67.99 - $132.89 $271 - $531
4 Added 400.0%
5 $372,000
Q2 2021

Jul 15, 2021

BUY
$80.99 - $107.93 $80 - $107
1 New
1 $427,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.